TransMedics (TMDX) Other financing activities (2018 - 2026)

TransMedics' Other financing activities history runs 9 years deep, the most recent figure standing at $2.2 million for Q1 2026.

• On a quarterly basis, Other financing activities rose 26.98% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $3.7 million, a 196.1% increase from a year earlier, with the FY2025 full-year figure at $3.2 million, up 57.64% from the prior year.
• Other financing activities improved to $2.2 million in Q1 2026 per TMDX's latest filing, from $2.0 million in the prior quarter.
• Across five years, Other financing activities topped out at $3.6 million in Q1 2023 and bottomed at -$3.3 million in Q3 2023.
• The 5-year median for Other financing activities is $1.1 million (2023), against an average of $641857.1.
• Across the five-year window, Other financing activities sank 3146.67% in 2022 and surged 1660.59% in 2023, its largest moves.
• Year by year, Other financing activities stood at -$1.4 million in 2022, then plunged by 142.45% to -$3.3 million in 2023, then soared by 142.81% to $1.4 million in 2024, then jumped by 37.95% to $2.0 million in 2025, then climbed by 12.68% to $2.2 million in 2026.
• Per Business Quant, the three latest TMDX Other financing activities figures stand at $2.2 million (Q1 2026), $2.0 million (Q3 2025), and -$456000.0 (Q2 2025).